On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates

BACKGROUND: Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors have been established as a standard treatment for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer (ABC); however, predictive biomarkers with translational relevance have no...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Chang Gon, Kim, Min Hwan, Kim, Jee Hung, Kim, Seul-Gi, Kim, Gun Min, Kim, Tae Yeong, Ryu, Won-Ji, Kim, Jee Ye, Park, Hyung Seok, Park, Seho, Cho, Young Up, Park, Byeong Woo, Kim, Seung Il, Jeong, Joon, Sohn, Joohyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838072/
https://www.ncbi.nlm.nih.gov/pubmed/36635767
http://dx.doi.org/10.1186/s13058-022-01601-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838072/
https://www.ncbi.nlm.nih.gov/pubmed/36635767
http://dx.doi.org/10.1186/s13058-022-01601-4

Ejemplares similares